<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intern Med</journal-id><journal-id journal-id-type="iso-abbrev">Intern. Med</journal-id><journal-id journal-id-type="doi">10.2169/internalmedicine.55.7297</journal-id><journal-title-group><journal-title>Internal Medicine</journal-title></journal-title-group><issn pub-type="ppub">0918-2918</issn><issn pub-type="epub">1349-7235</issn><publisher><publisher-name>The Japanese Society of Internal Medicine</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27904113</article-id><article-id pub-id-type="pmc">5216147</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Fanconi Syndrome Associated with Hyponatremia in Two Patients with <italic>Legionella</italic> Pneumonia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ryuge</surname><given-names>Akihiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ito</surname><given-names>Yasuhiko</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yamakawa</surname><given-names>Taishi</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tanaka</surname><given-names>Hitoshi</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Yasui</surname><given-names>Hirotoshi</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Mashimo</surname><given-names>Shuko</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Watanabe</surname><given-names>Kenshi</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nomura</surname><given-names>Rie</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Suganuma</surname><given-names>Nobukazu</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Maruyama</surname><given-names>Shoichi</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><aff id="aff1"><label>1</label>Department of Nephrology, Toyohashi Municipal Hospital, Japan</aff><aff id="aff2"><label>2</label>Department of Nephrology, Nagoya University Graduate School of Medicine, Japan</aff><aff id="aff3"><label>3</label>Department of General Medicine, Toyohashi Municipal Hospital, Japan</aff><aff id="aff4"><label>4</label>Department of Respiratory Medicine, Toyohashi Municipal Hospital, Japan</aff></contrib-group><author-notes><fn><p>Correspondence to Dr.&#x03000;Yasuhiko Ito, <email>yasuito@med.nagoya-u.ac.jp</email></p></fn></author-notes><pub-date pub-type="ppub"><day>1</day><month>12</month><year>2016</year></pub-date><volume>55</volume><issue>23</issue><fpage>3479</fpage><lpage>3484</lpage><history><date date-type="received"><day>18</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p><!--CREATIVE COMMONS-->The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic>Legionella pneumophila</italic> is a cause of community-acquired pneumonia that is reported to induce electrolyte disorders, including hyponatremia, hypokalemia, and hypophosphatemia. We herein report two Japanese men with <italic>Legionella</italic> pneumonia and hyponatremia and hypophosphatemia. These findings were associated with an elevation of urinary low-molecular-weight tubular protein, including urinary &#x003b2;2-microglobulin, N-acetyl-&#x003b2;-D-glucosaminidase, the fractional excretion of phosphate and uric acid, and the presence of glycosuria and panaminoaciduria, suggesting that their electrolyte disorders had been caused by Fanconi syndrome. In these two cases, hyponatremia was probably due to salt wasting. Electrolyte disorders caused by <italic>Legionella</italic> pneumonia are corrected by treatment of the primary disease and fluid administration. </p></abstract><kwd-group kwd-group-type="author"><kwd><italic>Legionella</italic> pneumonia</kwd><kwd>hyponatremia</kwd><kwd>hypophosphatemia</kwd><kwd>Fanconi syndrome</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>
<italic>Legionella pneumophila</italic> is a cause of community-acquired pneumonia that also induces electrolyte disorders, such as hyponatremia, hypokalemia, and hypophosphatemia. However, the mechanisms of these electrolyte disorders have not yet been clarified. We herein report two cases of <italic>Legionella</italic> pneumonia who presented with hyponatremia and hypophosphatemia, which may have been caused by Fanconi syndrome and renal salt wasting due to proximal tubular dysfunction.</p></sec><sec><title>Case Reports</title><sec><title>Case 1</title><p>A 65-year-old Japanese man was admitted to our hospital for fever and headache over the past 2 days. He had no relevant medical history, no history of infectious diseases or renal diseases, and he was not on any medication. On admission, physical examination indicated a blood pressure of 153/100 mmHg, pulse rate of 128 beats/min, and body temperature of 39.1&#x000b0;C. The patient was conscious and non-edematous, although his skin turgor had decreased. His laboratory findings on Day 2 (<xref ref-type="table" rid="t001">Table 1</xref>) were as follows: white blood cell count (WBC) 12,890/&#x003bc;L (Neutro: 91.7%, Eosino: 0.0%, Baso: 0.1%, Mono: 2.5%, Lymph: 5.7%), red blood cell count (RBC) 439&#x000d7;10<sup>4</sup>/&#x003bc;L, hemoglobin (Hb) 13.5 g/dL, hematocrit (Ht) 38.5%, platelet count (Plt) 16.6&#x000d7;10<sup>4</sup>/&#x003bc;L, aspartate aminotransferase (AST) 108 U/L, alanine aminotransferase (ALT) 52 U/L, blood urea nitrogen (BUN) 14 mg/dL, creatinine 0.85 mg/dL, creatine kinase (CK) 2,999 IU/L, C-reactive protein (CRP) 27.08 mg/dL, B-type natriuretic peptide (BNP) 23.9 pg/mL, proteinuria (++), glycosuria (++), and urine WBC (-). Antidiuretic hormone (ADH), plasma renin activity (PRA), and aldosterone were not measured. A computed tomography (CT) scan of the chest showed a ground-glass appearance in the left middle and lower lung lobes, and the urinary antigen test for <italic>Legionella pneumophila</italic> (Immunocatch<sup>&#x024c7;</sup>, Eiken Kagaku, Co., Ltd., Tokyo, Japan) was positive. We diagnosed his pneumonia as <italic>Legionella</italic> pneumonia based on these findings.</p><table-wrap id="t001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Laboratory Findings in the Two Cases.</p></caption><table frame="hsides" rules="groups"><thead style="border-top:solid thin; border-bottom:solid thin;"><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Laboratory investigation</bold></th><th valign="top" rowspan="1" colspan="1"><bold>Result of Case 1 </bold><break/><bold>(Day 2)</bold></th><th valign="top" rowspan="1" colspan="1"><bold>Result of Case 2 </bold><break/><bold>(On admission)</bold></th><th valign="top" rowspan="1" colspan="1"><bold>Reference range</bold></th></tr><tr><th colspan="4" style="border-top:solid thin; border-bottom:solid thin;" rowspan="1"><bold>Blood cell count</bold></th></tr></thead><tbody style="border-top:solid thin; border-bottom:solid thin;"><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> White blood cell count</bold></td><td align="center" rowspan="1" colspan="1">12.8&#x000d7;10<sup>3</sup>/&#x000b5;L</td><td align="center" rowspan="1" colspan="1">5.96&#x000d7;10<sup>3</sup>/&#x000b5;L</td><td align="center" rowspan="1" colspan="1">3.59-9.64&#x000d7;10<sup>3</sup>/&#x000b5;L</td></tr><tr><td style="padding-left:2em;" rowspan="1" colspan="1"><bold> Neutro</bold></td><td align="center" rowspan="1" colspan="1">91.7%</td><td align="center" rowspan="1" colspan="1">88.0%</td><td align="center" rowspan="1" colspan="1">41.2-74.7%</td></tr><tr><td style="padding-left:2em;" rowspan="1" colspan="1"><bold> Eosino</bold></td><td align="center" rowspan="1" colspan="1">0.0%</td><td align="center" rowspan="1" colspan="1">0.0%</td><td align="center" rowspan="1" colspan="1">0.2-8.4%</td></tr><tr><td style="padding-left:2em;" rowspan="1" colspan="1"><bold> Baso</bold></td><td align="center" rowspan="1" colspan="1">0.1%</td><td align="center" rowspan="1" colspan="1">0.0%</td><td align="center" rowspan="1" colspan="1">0.2-1.8%</td></tr><tr><td style="padding-left:2em;" rowspan="1" colspan="1"><bold> Mono</bold></td><td align="center" rowspan="1" colspan="1">2.5%</td><td align="center" rowspan="1" colspan="1">4.4%</td><td align="center" rowspan="1" colspan="1">3.1-8.0%</td></tr><tr><td style="padding-left:2em;" rowspan="1" colspan="1"><bold> Lymph</bold></td><td align="center" rowspan="1" colspan="1">5.7%</td><td align="center" rowspan="1" colspan="1">7.6%</td><td align="center" rowspan="1" colspan="1">21.2-51.0%</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Red blood cell count</bold></td><td align="center" rowspan="1" colspan="1">439&#x000d7;10<sup>4</sup>/&#x000b5;L</td><td align="center" rowspan="1" colspan="1">517&#x000d7;10<sup>4</sup>/&#x000b5;L</td><td align="center" rowspan="1" colspan="1">400-552&#x000d7;10<sup>4</sup>/&#x000b5;L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Hemoglobin</bold></td><td align="center" rowspan="1" colspan="1">13.5 g/dL</td><td align="center" rowspan="1" colspan="1">14.4 g/dL</td><td align="center" rowspan="1" colspan="1">13.2-17.2 g/dL</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Hematocrit</bold></td><td align="center" rowspan="1" colspan="1">38.5%</td><td align="center" rowspan="1" colspan="1">41.4%</td><td align="center" rowspan="1" colspan="1">40.4-51.1%</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Platelet count</bold></td><td align="center" rowspan="1" colspan="1">16.6&#x000d7;10<sup>4</sup>/&#x000b5;L</td><td align="center" rowspan="1" colspan="1">15.4n10<sup>4</sup>/&#x000b5;L</td><td align="center" rowspan="1" colspan="1">14.8-33.9&#x000d7;10<sup>4</sup>/&#x000b5;L</td></tr><tr><td align="center" colspan="4" style="border-top:solid thin; border-bottom:solid thin;" rowspan="1"><bold>Blood biochemistry</bold></td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Serum sodium</bold></td><td align="center" rowspan="1" colspan="1">128 mEq/L</td><td align="center" rowspan="1" colspan="1">128 mEq/L</td><td align="center" rowspan="1" colspan="1">138-146 mEq/L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Serum potassium</bold></td><td align="center" rowspan="1" colspan="1">3.6 mEq/L</td><td align="center" rowspan="1" colspan="1">3.3 mEq/L</td><td align="center" rowspan="1" colspan="1">3.6-4.9 mEq/L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Serum chloride</bold></td><td align="center" rowspan="1" colspan="1">91 mEq/L</td><td align="center" rowspan="1" colspan="1">93 mEq/L</td><td align="center" rowspan="1" colspan="1">99-109 mEq/L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Corrected serum calcium</bold></td><td align="center" rowspan="1" colspan="1">N.D.</td><td align="center" rowspan="1" colspan="1">8.9 mg/dL</td><td align="center" rowspan="1" colspan="1">8.7-10.3 mg/dL</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Serum phosphorus</bold></td><td align="center" rowspan="1" colspan="1">1.5 mg/dL</td><td align="center" rowspan="1" colspan="1">1.2 mg/dL</td><td align="center" rowspan="1" colspan="1">2.5-4.7 mg/dL</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urea nitrogen</bold></td><td align="center" rowspan="1" colspan="1">14 mg/dL</td><td align="center" rowspan="1" colspan="1">11 mg/dL</td><td align="center" rowspan="1" colspan="1">8-22 mg/dL</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Creatinine</bold></td><td align="center" rowspan="1" colspan="1">0.85 mg/dL</td><td align="center" rowspan="1" colspan="1">0.75 mg/dL</td><td align="center" rowspan="1" colspan="1">0.6-1.1 mg/dL</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Estimated GFR</bold></td><td align="center" rowspan="1" colspan="1">70 mL/min/1.73 m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">81 mL/min/1.73 m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">90-120 mL/min/1.73 m<sup>2</sup></td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Uric acid</bold></td><td align="center" rowspan="1" colspan="1">3.8 mg/dL</td><td align="center" rowspan="1" colspan="1">1.4 mg/dL</td><td align="center" rowspan="1" colspan="1">3.6-7.0 mg/dL</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Total protein</bold></td><td align="center" rowspan="1" colspan="1">6.1 g/dL</td><td align="center" rowspan="1" colspan="1">5.9 mg/dL</td><td align="center" rowspan="1" colspan="1">6.7-8.3 g/dL</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Albumin</bold></td><td align="center" rowspan="1" colspan="1">2.8 g/dL</td><td align="center" rowspan="1" colspan="1">2.8 mg/dL</td><td align="center" rowspan="1" colspan="1">3.9-4.9 g/dL</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Aspartate transaminase</bold></td><td align="center" rowspan="1" colspan="1">108 U/L</td><td align="center" rowspan="1" colspan="1">201 U/L</td><td align="center" rowspan="1" colspan="1">13-33 U/L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Alanine transaminase</bold></td><td align="center" rowspan="1" colspan="1">52 U/L</td><td align="center" rowspan="1" colspan="1">84 U/L</td><td align="center" rowspan="1" colspan="1">6-30 U/L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Alkali phosphatase</bold></td><td align="center" rowspan="1" colspan="1">152 U/L</td><td align="center" rowspan="1" colspan="1">124 U/L</td><td align="center" rowspan="1" colspan="1">115-359 U/L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> &#x003b3;-glutamyltransfer</bold></td><td align="center" rowspan="1" colspan="1">24 U/L</td><td align="center" rowspan="1" colspan="1">28 U/L</td><td align="center" rowspan="1" colspan="1">10-47 U/L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Creatinine kinase</bold></td><td align="center" rowspan="1" colspan="1">2,999 IU/L</td><td align="center" rowspan="1" colspan="1">12,675 IU/L</td><td align="center" rowspan="1" colspan="1">62-287 IU/L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Lactate Dehydrogenase</bold></td><td align="center" rowspan="1" colspan="1">398 U/L</td><td align="center" rowspan="1" colspan="1">673 U/L</td><td align="center" rowspan="1" colspan="1">119-229 U/L</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> C-reactive protein</bold></td><td align="center" rowspan="1" colspan="1">27.08 mg/dL</td><td align="center" rowspan="1" colspan="1">19.86 mg/dL</td><td align="center" rowspan="1" colspan="1">0-0.3 mg/dL</td></tr><tr><td align="center" colspan="4" rowspan="1"><bold>Arterial blood gas</bold></td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> pH</bold></td><td align="center" rowspan="1" colspan="1">7.494</td><td align="center" rowspan="1" colspan="1">7.540</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> PaO<sub>2</sub></bold></td><td align="center" rowspan="1" colspan="1">64.5 mmHg</td><td align="center" rowspan="1" colspan="1">62.4 mmHg</td><td align="center" rowspan="1" colspan="1">80-100 mmHg</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> PaCO<sub>2</sub></bold></td><td align="center" rowspan="1" colspan="1">23.4 mmHg</td><td align="center" rowspan="1" colspan="1">21.7 mmHg</td><td align="center" rowspan="1" colspan="1">35-45 mmHg</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> HCO<sub>3</sub><sup>-</sup></bold></td><td align="center" rowspan="1" colspan="1">17.9 mmol/L</td><td align="center" rowspan="1" colspan="1">18.5 mmol/L</td><td align="center" rowspan="1" colspan="1">22-26 mmol/L</td></tr><tr><td colspan="4" align="center" style="border-top:solid thin; border-bottom:solid thin;" rowspan="1"><bold>Urine</bold></td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urine protein</bold></td><td align="center" rowspan="1" colspan="1">2+</td><td align="center" rowspan="1" colspan="1">2+</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urine occult blood reaction</bold></td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">3+</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urine glucose</bold></td><td align="center" rowspan="1" colspan="1">2+</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urine WBC</bold></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">&#x000b1;</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urine sodium</bold></td><td align="center" rowspan="1" colspan="1">64.6 mmol/L</td><td align="center" rowspan="1" colspan="1">43.8 mmol/L</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urine potassium</bold></td><td align="center" rowspan="1" colspan="1">42.8 mmol/L</td><td align="center" rowspan="1" colspan="1">31.2 mmol/L</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urine chloride</bold></td><td align="center" rowspan="1" colspan="1">54.5 mmol/L</td><td align="center" rowspan="1" colspan="1">49.0 mmol/L</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urine creatinine</bold></td><td align="center" rowspan="1" colspan="1">120.59 mg/dL</td><td align="center" rowspan="1" colspan="1">109.61 mg/dL</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urine urea nitrogen</bold></td><td align="center" rowspan="1" colspan="1">742.8 mg/dL</td><td align="center" rowspan="1" colspan="1">982.1 mg/dL</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Urinary osmolality</bold></td><td align="center" rowspan="1" colspan="1">570 mOsm/kg H<sub>2</sub>O</td><td align="center" rowspan="1" colspan="1">628 mOsm/kg H<sub>2</sub>O</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="border-top:solid thin; border-bottom:solid thin;" rowspan="1" colspan="1"><bold>Fraction Excretion</bold></td><td style="border-top:solid thin; border-bottom:solid thin;" align="center" rowspan="1" colspan="1"/><td style="border-top:solid thin; border-bottom:solid thin;" align="center" rowspan="1" colspan="1"/><td style="border-top:solid thin; border-bottom:solid thin;" align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Sodium</bold></td><td align="center" rowspan="1" colspan="1">0.36%</td><td align="center" rowspan="1" colspan="1">0.2%</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Uric acid</bold></td><td align="center" rowspan="1" colspan="1">11.7%</td><td align="center" rowspan="1" colspan="1">18.6% (Day 2)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> Phosphate</bold></td><td align="center" rowspan="1" colspan="1">52.1%</td><td align="center" rowspan="1" colspan="1">18.9%</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="border-top:solid thin; border-bottom:solid thin;" rowspan="1" colspan="1"><bold>Endocrinological data</bold></td><td style="border-top:solid thin; border-bottom:solid thin;" align="center" rowspan="1" colspan="1"/><td style="border-top:solid thin; border-bottom:solid thin;" align="center" rowspan="1" colspan="1"/><td style="border-top:solid thin; border-bottom:solid thin;" align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:1em;" rowspan="1" colspan="1"><bold> BNP (type B natriuretic peptide)</bold></td><td align="center" rowspan="1" colspan="1">23.9 pg/mL</td><td align="center" rowspan="1" colspan="1">60.9 pg/mL</td><td align="center" rowspan="1" colspan="1">&#x0003c;18.4 pg/mL</td></tr></tbody></table><table-wrap-foot><fn><p>N.D. not determined.</p></fn></table-wrap-foot></table-wrap><p>As shown in <xref ref-type="table" rid="t001">Table 1</xref>, hyponatremia, hypophosphatemia, and hypouricemia existed at the time of his admission. Hypophosphatemia and hypouricemia were associated with an elevation of the fractional excretion of phosphate (FEP, 52.1%) and uric acid (FEUA, 11.7%). Furthermore, elevated levels of urine low-molecular-weight tubular proteins, including urinary &#x003b2;2-microglobulin (&#x003b2;2MG) and N-acetyl-&#x003b2;-D-glucosaminidase (NAG), and the presence of glycosuria and panaminoaciduria as assessed via high-performance liquid chromatography (L-8500, Hitachi, Tokyo, Japan) were detected (<xref ref-type="table" rid="t002">Table 2</xref>). These findings suggested that his hypophosphatemia and hypouricemia were secondary to Fanconi syndrome. With regard to hyponatremia, the presence of hypouricemia and the elevation of both FEUA and FEP suggested that the cause of hyponatremia was renal salt wasting (<xref rid="B1" ref-type="bibr">1</xref>). In addition, his physical findings suggested he was volume-depleted, which was consistent with renal salt wasting. For these reasons, we commenced the intravenous administration of azithromycin with normal saline and Ringer's solution without fluid restriction, a regimen which gradually improved his electrolyte imbalance (<xref ref-type="fig" rid="g001">Figure</xref>). Once fluid administration was commenced, his urinary osmolality decreased, which is consistent with renal salt wasting (<xref ref-type="fig" rid="g001">Figure</xref>). Two weeks of this treatment improved his general condition and electrolyte imbalance.</p><table-wrap id="t002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Urinary Amino Acid Levels in the Two Cases.</p></caption><table frame="hsides" rules="groups"><thead style="border-top:solid thin; border-bottom:solid thin;"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Normal range (&#x003bc;mol/day*)</th><th rowspan="1" colspan="1">Case 1</th><th rowspan="1" colspan="1">Case 2</th></tr></thead><tbody style="border-top:solid thin; border-bottom:solid thin;"><tr><td rowspan="1" colspan="1">Taurine</td><td rowspan="1" colspan="1">322.2-5214.5</td><td rowspan="1" colspan="1">2,147.9</td><td rowspan="1" colspan="1">2,680.1</td></tr><tr><td rowspan="1" colspan="1">Phosphoethanolamine</td><td rowspan="1" colspan="1">31.0-110.0</td><td rowspan="1" colspan="1">105.7</td><td rowspan="1" colspan="1">X</td></tr><tr><td rowspan="1" colspan="1">Urea</td><td rowspan="1" colspan="1">130.3-493.2</td><td rowspan="1" colspan="1">182.7</td><td rowspan="1" colspan="1">228.1</td></tr><tr><td rowspan="1" colspan="1">Aspartic acid</td><td rowspan="1" colspan="1">&#x0003c; 12.7</td><td rowspan="1" colspan="1">8.6</td><td rowspan="1" colspan="1">5.8</td></tr><tr><td rowspan="1" colspan="1">Hydroxyproline</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">Threonine</td><td rowspan="1" colspan="1">79.9-528.3</td><td rowspan="1" colspan="1"><underline>603.8</underline></td><td rowspan="1" colspan="1">205.8</td></tr><tr><td rowspan="1" colspan="1">Serine</td><td rowspan="1" colspan="1">208.8-1,020.0</td><td rowspan="1" colspan="1"><underline>1,132.2</underline></td><td rowspan="1" colspan="1">570.9</td></tr><tr><td rowspan="1" colspan="1">Asparagine</td><td rowspan="1" colspan="1">60.7-372.3</td><td rowspan="1" colspan="1"><underline>597.1</underline></td><td rowspan="1" colspan="1"><underline>372.5</underline></td></tr><tr><td rowspan="1" colspan="1">Glutamic acid</td><td rowspan="1" colspan="1">11.3-42.7</td><td rowspan="1" colspan="1">34.6</td><td rowspan="1" colspan="1">31.9</td></tr><tr><td rowspan="1" colspan="1">Glutamine</td><td rowspan="1" colspan="1">207.0-1,357.3</td><td rowspan="1" colspan="1">579.3</td><td rowspan="1" colspan="1">530.1</td></tr><tr><td rowspan="1" colspan="1">Sarcosine</td><td rowspan="1" colspan="1">&#x0003c; 99.0</td><td rowspan="1" colspan="1">40.0</td><td rowspan="1" colspan="1">31.6</td></tr><tr><td rowspan="1" colspan="1">&#x003b1;-Aminoadipic acid</td><td rowspan="1" colspan="1">16.7-118.6</td><td rowspan="1" colspan="1">55.4</td><td rowspan="1" colspan="1">41.2</td></tr><tr><td rowspan="1" colspan="1">Proline</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">Glycine</td><td rowspan="1" colspan="1">652.1-3,670.6</td><td rowspan="1" colspan="1">658.1</td><td rowspan="1" colspan="1">462.7</td></tr><tr><td rowspan="1" colspan="1">Alanine</td><td rowspan="1" colspan="1">141.2-833.9</td><td rowspan="1" colspan="1">812.6</td><td rowspan="1" colspan="1">710.0</td></tr><tr><td rowspan="1" colspan="1">Citrulline</td><td rowspan="1" colspan="1">13.5-55.6</td><td rowspan="1" colspan="1"><underline>87.2</underline></td><td rowspan="1" colspan="1">26.1</td></tr><tr><td rowspan="1" colspan="1">&#x003b1;-Aminobutylic acid</td><td rowspan="1" colspan="1">&#x0003c; 27.1</td><td rowspan="1" colspan="1"><underline>29.3</underline></td><td rowspan="1" colspan="1"><underline>35.4</underline></td></tr><tr><td rowspan="1" colspan="1">Valine</td><td rowspan="1" colspan="1">24.8-82.2</td><td rowspan="1" colspan="1"><underline>96.6</underline></td><td rowspan="1" colspan="1"><underline>87.5</underline></td></tr><tr><td rowspan="1" colspan="1">Cystine</td><td rowspan="1" colspan="1">23.7-170.9</td><td rowspan="1" colspan="1"><underline>252.0</underline></td><td rowspan="1" colspan="1">94.2</td></tr><tr><td rowspan="1" colspan="1">Cystathionine</td><td rowspan="1" colspan="1">&#x0003c; 44.7</td><td rowspan="1" colspan="1">28.0</td><td rowspan="1" colspan="1">28.1</td></tr><tr><td rowspan="1" colspan="1">Methionine</td><td rowspan="1" colspan="1">&#x0003c; 20.2</td><td rowspan="1" colspan="1">11.3</td><td rowspan="1" colspan="1">8.2</td></tr><tr><td rowspan="1" colspan="1">Isoleucine</td><td rowspan="1" colspan="1">7.5-23.5</td><td rowspan="1" colspan="1">16.2</td><td rowspan="1" colspan="1">13.7</td></tr><tr><td rowspan="1" colspan="1">Leucine</td><td rowspan="1" colspan="1">24.6-89.3</td><td rowspan="1" colspan="1">82.0</td><td rowspan="1" colspan="1">55.8</td></tr><tr><td rowspan="1" colspan="1">Tyrosine</td><td rowspan="1" colspan="1">50.6-308.4</td><td rowspan="1" colspan="1"><underline>345.3</underline></td><td rowspan="1" colspan="1">195.2</td></tr><tr><td rowspan="1" colspan="1">Phenylalanine</td><td rowspan="1" colspan="1">27.2-110.2</td><td rowspan="1" colspan="1"><underline>457.9</underline></td><td rowspan="1" colspan="1"><underline>378.7</underline></td></tr><tr><td rowspan="1" colspan="1">&#x003b3;-Amino &#x003b2;-hydroxybutyric acid</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">&#x003b2;-Alanine</td><td rowspan="1" colspan="1">&#x0003c; 153.0</td><td rowspan="1" colspan="1">8.2</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">&#x003b2;-Amino-iso-butyric acid</td><td rowspan="1" colspan="1">&#x0003c; 1,623.9 </td><td rowspan="1" colspan="1">333.0</td><td rowspan="1" colspan="1">1,395.1</td></tr><tr><td rowspan="1" colspan="1">&#x003b3;-Aminobutyric acid</td><td rowspan="1" colspan="1">N.D</td><td rowspan="1" colspan="1">X</td><td rowspan="1" colspan="1">X</td></tr><tr><td rowspan="1" colspan="1">Monoethanolamine</td><td rowspan="1" colspan="1">195.3-606.2</td><td rowspan="1" colspan="1">296.2</td><td rowspan="1" colspan="1">258.5</td></tr><tr><td rowspan="1" colspan="1">Homocystine</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">Histidine</td><td rowspan="1" colspan="1">436.4-2,786.5</td><td rowspan="1" colspan="1">1,357.0</td><td rowspan="1" colspan="1">1,021.9</td></tr><tr><td rowspan="1" colspan="1">3-Methylhistidine</td><td rowspan="1" colspan="1">113.4-480.9</td><td rowspan="1" colspan="1">272.5</td><td rowspan="1" colspan="1">267.3</td></tr><tr><td rowspan="1" colspan="1">1-Methylhistidine</td><td rowspan="1" colspan="1">59.3-2,816.2</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">T.R.</td></tr><tr><td rowspan="1" colspan="1">Carnosine</td><td rowspan="1" colspan="1">&#x0003c; 87.6</td><td rowspan="1" colspan="1">19.0</td><td rowspan="1" colspan="1">19.9</td></tr><tr><td rowspan="1" colspan="1">Anserine</td><td rowspan="1" colspan="1">&#x0003c; 231.4</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">Tryptophan</td><td rowspan="1" colspan="1">20.7-150.7</td><td rowspan="1" colspan="1"><underline>263.3</underline></td><td rowspan="1" colspan="1">X</td></tr><tr><td rowspan="1" colspan="1">Hydroxylysine</td><td rowspan="1" colspan="1">&#x0003c; 22.9</td><td rowspan="1" colspan="1">2.8</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">Ornithine</td><td rowspan="1" colspan="1">6.9-43.9</td><td rowspan="1" colspan="1"><underline>67.1</underline></td><td rowspan="1" colspan="1">36.3</td></tr><tr><td rowspan="1" colspan="1">Lysine</td><td rowspan="1" colspan="1">51.6-1,639.6</td><td rowspan="1" colspan="1">290.3</td><td rowspan="1" colspan="1">74.3</td></tr><tr><td rowspan="1" colspan="1">Arginine</td><td rowspan="1" colspan="1">11.6-54.8</td><td rowspan="1" colspan="1">16.8</td><td rowspan="1" colspan="1">16.9</td></tr></tbody></table><table-wrap-foot><fn><p>Underlining indicates an abnormal value.</p><p>N.D. means not detected.</p><p>X means not measured.</p><p>*Urea: mmol/day.</p></fn></table-wrap-foot></table-wrap><fig id="g001" orientation="portrait" position="float"><label>Figure.</label><caption><p>Clinical course of cases 1 and 2. AZM: Azithromycin, LVFX: Levofloxacin, FGF-23: fibroblast growth factor 23, U-&#x003b2;2 MG: urinary &#x003b2;2-microglobulin, U-NAG: urinary N-acetyl-beta-D-glucosaminidase, CRP: C-reactive protein, UA: Uric acid, FE: fractional excretion, Osm: Osmolality</p></caption><graphic xlink:href="1349-7235-55-3479-g001-001"/><graphic xlink:href="1349-7235-55-3479-g001-002"/></fig></sec><sec><title>Case 2</title><p>A 63-year-old Japanese man was admitted to our hospital for fever, cough, and diarrhea. He had a medical history of cerebral infarction, gastric ulcer, and polycythemia vera, and was being treated with clopidogrel, nizatidine, and camostat mesilate. Physical examination on admission indicated a blood pressure of 159/89 mmHg, pulse rate of 102 beats/min, and body temperature of 39.7&#x000b0;C. He was conscious and non-edematous, and he complained of dryness of the mouth. His laboratory findings (<xref ref-type="table" rid="t001">Table 1</xref>) at admission were as follows: WBC 5,960/&#x003bc;L (Neutro: 88.0%, Eosino: 0.0%, Baso: 0.0%, Mono: 4.4%, Lymph: 7.6%), RBC 517&#x000d7;10<sup>4</sup>/&#x003bc;L, Hb 14.4 g/dL, Ht 41.4%, Plt 15.4&#x000d7;10<sup>4</sup>/&#x003bc;L, AST 201 U/L, ALT 84 U/L, BUN 11 mg/dL, creatinine 0.75 mg/dL, CK 12,675 IU/L, CRP 19.86 mg/dL, BNP 60.9 pg/mL, proteinuria (++), glycosuria (+), and urine WBC (&#x000b1;). ADH, PRA, and aldosterone were not measured. A chest CT scan showed a ground-glass appearance in the right lower lung lobe, and the urinary antigen test for <italic>Legionella pneumophila</italic> was positive. These findings suggested a diagnosis of <italic>Legionella</italic> pneumonia.</p><p>As shown in <xref ref-type="table" rid="t001">Table 1</xref>, hyponatremia, hypophosphatemia, and hypouricemia existed at the time of his admission. Despite the hypophosphatemia and hypouricemia, both FEP and FEUA were elevated. Furthermore, elevated levels of low-molecular-weight tubular protein, including urinary &#x003b2;2MG and NAG, and the presence of glycosuria and panaminoaciduria were detected (<xref ref-type="table" rid="t002">Table 2</xref>). These findings suggested that his hypophosphatemia and hypouricemia had been caused by Fanconi syndrome. As in the previous case, the presence of hypouricemia and elevated FEUA (18.6%) and FEP (18.9%) suggested that the cause of hyponatremia was renal salt wasting (<xref rid="B1" ref-type="bibr">1</xref>). In addition, his physical findings suggested he was volume-depleted, which was also consistent with renal salt wasting. For these reasons, we commenced the intravenous administration of levofloxacin with normal saline and Ringer's solution without fluid restriction, a regimen which gradually improved his electrolyte imbalance. The administration of Ringer's solution caused his urinary osmolality to decrease, which is consistent with renal salt wasting (<xref ref-type="fig" rid="g001">Figure</xref>). Two weeks of this treatment improved his general condition and electrolyte imbalance.</p></sec></sec><sec><title>Discussion</title><p>The two cases described herein shared two important clinical features: Hypophosphatemia and hypouricemia were caused by Fanconi syndrome, and hyponatremia seemed to not be caused by syndrome of inappropriate antidiuretic hormone secretion (SIADH), but by renal salt wasting due to proximal tubular dysfunction.</p><p>In these two cases, hypophosphatemia and hypouricemia associated with <italic>Legionella</italic> pneumonia had been caused by Fanconi syndrome. The renal manifestations of <italic>Legionella</italic> pneumonia reportedly include microscopic hematuria, acute kidney injury due to rhabdomyolysis (<xref rid="B2" ref-type="bibr">2</xref>-<xref rid="B4" ref-type="bibr">4</xref>), acute tubular necrosis (<xref rid="B5" ref-type="bibr">5</xref>), and acute tubulointerstitial nephritis (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>). One previous article from Japan reported that two patients with <italic>Legionella</italic> pneumonia showed Fanconi syndrome (<xref rid="B7" ref-type="bibr">7</xref>), which is characterized by a dysfunction of the proximal tubule leading to elevated urinary excretion of amino acids, glucose, phosphate, and uric acid (<xref rid="B8" ref-type="bibr">8</xref>). The authors concluded that <italic>Legionella pneumophila</italic> might infect the proximal tubular cells, induce mitochondrial dysfunction, and cause Fanconi syndrome (<xref rid="B7" ref-type="bibr">7</xref>). In our two cases, the laboratory findings, which included elevated FEUA, FEP, urinary &#x003b2;2MG, and urinary NAG, and the presence of glycosuria and panaminoaciduria, were consistent with Fanconi syndrome. Interestingly, in both cases, fibroblast growth factor (FGF)-23 at admission, determined by an enzyme-linked immunosorbent assay (ELISA) kit (Kainos Laboratories, Tokyo, Japan), was not elevated despite the increase in FEP, which is also consistent with Fanconi syndrome. Of further note, our cases lacked any other etiology for Fanconi syndrome, such as drug therapy (with cisplatin, ifosfamide, tenofovir, cidofovir, adefovir, didanosine, gentamicin, azathioprine, etc.) or heavy metal poisoning, and their abnormal laboratory data rapidly normalized with treatment of the <italic>Legionella</italic> pneumonia. As described in a previous case report (<xref rid="B7" ref-type="bibr">7</xref>), we speculated that Fanconi syndrome in these patients had been caused by <italic>Legionella</italic> pneumonia. In both the previous cases (<xref rid="B7" ref-type="bibr">7</xref>) and our cases, Fanconi syndrome was successfully treated by treating the primary disease.</p><p>In our patients, the clinical course of hyponatremia suggested that its etiology was more likely to be renal salt wasting than SIADH. Hyponatremia often occurs in <italic>Legionella</italic> pneumonia patients (<xref rid="B9" ref-type="bibr">9</xref>-<xref rid="B14" ref-type="bibr">14</xref>). Although it is crucial for physicians to understand the various etiologies of hyponatremia, as their treatments differ, the mechanism of hyponatremia in <italic>Legionella</italic> pneumonia has not yet been clarified. The main cause of hyponatremia due to <italic>Legionella</italic> pneumonia is reportedly SIADH (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>). However, Schuetz et al. reported that, although the serum sodium levels in patients with <italic>Legionella</italic> pneumonia are much lower than those due to other causes of community-acquired pneumonia, the level of Copeptin (CT-ProVasopressin), which is a precursor of ADH, is not significantly elevated (<xref rid="B17" ref-type="bibr">17</xref>). They concluded that salt loss might be a cause of hyponatremia and recommended hydration and salt repletion for treatment (<xref rid="B17" ref-type="bibr">17</xref>). In our cases, we postulated that hyponatremia due to <italic>Legionella</italic> pneumonia had been caused by renal salt wasting due to proximal tubular dysfunction. Recently, several important diagnostic markers have been proposed to distinguish SIADH from renal salt wasting. Bitew et al. reported that patients with renal salt wasting showed elevated FEP due to proximal tubular dysfunction (<xref rid="B18" ref-type="bibr">18</xref>). Maesaka et al. reported that saline infusion reduced ADH secretion caused by volume depletion, thereby resulting in excretion of dilute urine and correction of hyponatremia in renal salt wasting patients (<xref rid="B19" ref-type="bibr">19</xref>). Maesaka et al. further reported that FEUA exceeding 11% is consistent with both SIADH and renal salt wasting (<xref rid="B20" ref-type="bibr">20</xref>). In our cases, both FEUA and FEP were elevated, and urinary osmolality decreased by administration of saline and Ringer's solution (<xref ref-type="fig" rid="g001">Figure</xref>), suggesting that the condition was due to renal salt wasting. Furthermore, a previous article reported that hyponatremia caused by SIADH either does not improve or is aggravated by isotonic saline administration (<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>). This phenomenon is most likely to occur when the patient's urinary osmolality is above 530 mOsm/kg (<xref rid="B23" ref-type="bibr">23</xref>). In spite of the high urinary osmolality in our cases, their hyponatremia rapidly responded to the administration of saline and Ringer's solution, which is contrary to what occurs with SIADH.</p><p>However, the findings in our patients had some discrepancies with renal salt wasting. First, while fractional excretion of sodium (FENa) is usually increased in salt wasting, it was not elevated in both of our cases. However, urinary Na exceeded 40 mmol/L in both cases. The previous cases of renal salt wasting described by Maesaka et al. also presented decreased urinary Na and FENa (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>), and the authors concluded that these parameters might have been low due to reduced sodium ingestion (<xref rid="B1" ref-type="bibr">1</xref>). Second, in patients with renal salt wasting, FEUA is reported to remain above 11% after correction of hyponatremia, but it normalizes after treatment of SIADH (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B20" ref-type="bibr">20</xref>). In our case 2, the elevated FEUA resolved after improvement of hyponatremia. The precise reason for this is not clear, but we speculate that rapid improvement of proximal tubular dysfunction may have affected improvement of FEUA (<xref ref-type="fig" rid="g001">Figure</xref>).</p><p>As a limitation associated with our report, we did not measure the hormone levels, including thyroid hormone, cortisol, ADH, plasma renin activity, and aldosterone. However, in both our cases, hyponatremia improved by fluid administration, and normonatremia was maintained after treatment. This suggests that their diagnosis was neither hypothyroidism nor adrenal insufficiency. Reportedly, an elevated plasma renin activity and increased plasma aldosterone levels support the diagnosis of renal salt wasting (<xref rid="B1" ref-type="bibr">1</xref>). However, a recent review stated that it is difficult to evaluate these data in hyponatremic patients because their levels are affected by saline infusion, and hence, FEUA should be used to diagnose this condition (<xref rid="B20" ref-type="bibr">20</xref>).</p><p>We herein reported two cases of <italic>Legionella</italic> pneumonia that were associated with Fanconi syndrome and hyponatremia. In such patients, the electrolyte imbalance should be corrected by treatment of the primary disease, with additional consideration of fluid administration. FEUA and monitoring the urinary osmolality during the administration of saline may be useful in diagnosing salt wasting. Further studies are needed to clarify the mechanisms of hyponatremia in <italic>Legionella</italic> pneumonia.</p><p>
<bold>Authorship: </bold>All authors had full access to the data and played a role in writing this manuscript.</p></sec><sec><title>The authors state that they have no Conflict of Interest (COI).</title></sec></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maesaka</surname><given-names>JK</given-names></name>, <name><surname>Imbriano</surname><given-names>LJ</given-names></name>, <name><surname>Ali</surname><given-names>NM</given-names></name>, <name><surname>Ilamathi</surname><given-names>E</given-names></name></person-group>
<article-title>Is it cerebral or renal salt wasting?</article-title>
<source>Kidney Int</source>
<volume>76</volume>: <fpage>934</fpage>-<lpage>938</lpage>, <year>2009</year>.<pub-id pub-id-type="pmid">19641485</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shah</surname><given-names>A</given-names></name>, <name><surname>Check</surname><given-names>F</given-names></name>, <name><surname>Baskin</surname><given-names>S</given-names></name>, <name><surname>Reyman</surname><given-names>T</given-names></name>, <name><surname>Menard</surname><given-names>R</given-names></name></person-group>
<article-title>Legionnaires' disease and acute renal failure: case report and review</article-title>. <source>Clin Infect Dis</source>
<volume>14</volume>: <fpage>204</fpage>-<lpage>207</lpage>, <year>1992</year>.<pub-id pub-id-type="pmid">1571431</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abe</surname><given-names>M</given-names></name>, <name><surname>Kaizu</surname><given-names>K</given-names></name>, <name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group>
<article-title>Clinical evaluation of pneumonia-associated rhabdomyolysis with acute renal failure</article-title>. <source>Ther Apher Dial</source>
<volume>12</volume>: <fpage>171</fpage>-<lpage>175</lpage>, <year>2008</year>.<pub-id pub-id-type="pmid">18387168</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McConkey</surname><given-names>J</given-names></name>, <name><surname>Obeius</surname><given-names>M</given-names></name>, <name><surname>Valentini</surname><given-names>J</given-names></name>, <name><surname>Beeson</surname><given-names>MS</given-names></name></person-group>
<article-title><italic>Legionella</italic> pneumonia presenting with rhabdomyolysis and acute renal failure: a case report</article-title>. <source>J Emerg Med</source>
<volume>30</volume>: <fpage>389</fpage>-<lpage>392</lpage>, <year>2006</year>.<pub-id pub-id-type="pmid">16740446</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nishitarumizu</surname><given-names>K</given-names></name>, <name><surname>Tokuda</surname><given-names>Y</given-names></name>, <name><surname>Uehara</surname><given-names>H</given-names></name>, <name><surname>Taira</surname><given-names>M</given-names></name>, <name><surname>Taira</surname><given-names>K</given-names></name></person-group>
<article-title>Tubulointerstitial nephritis associated with Legionnaires' disease</article-title>. <source>Intern Med</source>
<volume>39</volume>: <fpage>150</fpage>-<lpage>153</lpage>, <year>2000</year>.<pub-id pub-id-type="pmid">10732834</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daumas</surname><given-names>A</given-names></name>, <name><surname>El-Mekaoui</surname><given-names>F</given-names></name>, <name><surname>Bataille</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Acute tubulointerstitial nephritis complicating Legionnaires' disease: a case report</article-title>. <source>J Med Case Rep</source>
<volume>6</volume>: <fpage>100</fpage>, <year>2012</year>.<pub-id pub-id-type="pmid">22475340</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kinoshita-Katahashi</surname><given-names>N</given-names></name>, <name><surname>Fukasawa</surname><given-names>H</given-names></name>, <name><surname>Ishigaki</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Acquired Fanconi syndrome in patients with <italic>Legionella</italic> pneumonia</article-title>. <source>BMC Nephrol</source>
<volume>14</volume>: <fpage>171</fpage>, <year>2013</year>.<pub-id pub-id-type="pmid">23915094</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Foreman</surname><given-names>JW</given-names></name>. </person-group><article-title>Fanconi syndrome and other proximal tubule disorders</article-title>. In: <source>Comprehensive Clinical Nephrology</source>. <edition>5th ed.</edition>
<person-group><name name-style="western"><surname>Johnson</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Feehally</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Floege</surname><given-names>J</given-names></name></person-group>, Eds. <publisher-name>Saunders Elsevier</publisher-name>, <publisher-loc>Philadelphia</publisher-loc>, <year>2014</year>: <fpage>590</fpage>-<lpage>600</lpage>.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cunha</surname><given-names>BA</given-names></name></person-group>
<article-title>The clinical diagnosis of Legionnaires' disease: the diagnostic value of combining non-specific laboratory tests</article-title>. <source>J Infect</source>
<volume>56</volume>: <fpage>395</fpage>-<lpage>397</lpage>, <year>2008</year>.<pub-id pub-id-type="pmid">18410967</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carratal&#x000e0;</surname><given-names>J</given-names></name>, <name><surname>Garcia-Vidal</surname><given-names>C</given-names></name></person-group>
<article-title>An update on <italic>Legionella</italic></article-title>. <source>Curr Opin Infect Dis</source>
<volume>23</volume>: <fpage>152</fpage>-<lpage>157</lpage>, <year>2010</year>.<pub-id pub-id-type="pmid">20051846</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fiumefreddo</surname><given-names>R</given-names></name>, <name><surname>Zaborsky</surname><given-names>R</given-names></name>, <name><surname>Haeuptle</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinical predictors for <italic>Legionella</italic> in patients presenting with community-acquired pneumonia to the emergency department</article-title>. <source>BMC Pulm Med</source>
<volume>9</volume>: <fpage>4</fpage>, <year>2009</year>.<pub-id pub-id-type="pmid">19152698</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sopena</surname><given-names>N</given-names></name>, <name><surname>Force</surname><given-names>L</given-names></name>, <name><surname>Pedro-Botet</surname><given-names>ML</given-names></name>, <etal>et al</etal></person-group>
<article-title>Sporadic and epidemic community legionellosis: two faces of the same illness</article-title>. <source>Eur Respir J</source>
<volume>29</volume>: <fpage>138</fpage>-<lpage>142</lpage>, <year>2007</year>.<pub-id pub-id-type="pmid">17005576</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>JA</given-names></name>, <name><surname>L&#x000f3;pez</surname><given-names>P</given-names></name>, <name><surname>Orozco</surname><given-names>D</given-names></name>, <name><surname>Merino</surname><given-names>J</given-names></name></person-group>
<article-title>Clinical study of an outbreak of Legionnaire's disease in Alcoy, Southeastern Spain</article-title>. <source>Eur J Clin Microbiol Infect Dis</source>
<volume>21</volume>: <fpage>729</fpage>-<lpage>735</lpage>, <year>2002</year>.<pub-id pub-id-type="pmid">12415472</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liamis</surname><given-names>G</given-names></name>, <name><surname>Milionis</surname><given-names>HJ</given-names></name>, <name><surname>Elisaf</surname><given-names>M</given-names></name></person-group>
<article-title>Hyponatremia in patients with infectious diseases</article-title>. <source>J Infect</source>
<volume>63</volume>: <fpage>327</fpage>-<lpage>335</lpage>, <year>2011</year>.<pub-id pub-id-type="pmid">21835196</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dixon</surname><given-names>BS</given-names></name>, <name><surname>Anderson</surname><given-names>RJ</given-names></name></person-group>
<article-title>Pneumonia and the syndrome of inappropriate antidiuretic hormone secretion: don't pour water on the fire</article-title>. <source>Am Rev Respir Dis</source>
<volume>138</volume>: <fpage>512</fpage>-<lpage>513</lpage>, <year>1988</year>.<pub-id pub-id-type="pmid">3202405</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cunha</surname><given-names>BA</given-names></name></person-group>
<article-title>Legionnaires' disease: clinical differentiation from typical and other atypical pneumonias</article-title>. <source>Infect Dis Clin North Am</source>
<volume>24</volume>: <fpage>73</fpage>-<lpage>105</lpage>, <year>2010</year>.<pub-id pub-id-type="pmid">20171547</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schuetz</surname><given-names>P</given-names></name>, <name><surname>Haubitz</surname><given-names>S</given-names></name>, <name><surname>Christ-Crain</surname><given-names>M</given-names></name>, <name><surname>Albrich</surname><given-names>WC</given-names></name>, <name><surname>Zimmerli</surname><given-names>W</given-names></name>, <name><surname>Mueller</surname><given-names>B</given-names></name>; </person-group><person-group person-group-type="author"><collab>ProHOSP Study Group</collab>. </person-group><article-title>Hyponatremia and anti-diuretic hormone in Legionnaires' disease</article-title>. <source>BMC Infect Dis</source>
<volume>13</volume>: <fpage>585</fpage>, <year>2013</year>.<pub-id pub-id-type="pmid">24330484</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bitew</surname><given-names>S</given-names></name>, <name><surname>Imbriano</surname><given-names>L</given-names></name>, <name><surname>Miyawaki</surname><given-names>N</given-names></name>, <name><surname>Fishbane</surname><given-names>S</given-names></name>, <name><surname>Maesaka</surname><given-names>JK</given-names></name></person-group>
<article-title>More on renal salt wasting without cerebral disease: response to saline infusion</article-title>. <source>Clin J Am Soc Nephrol</source>
<volume>4</volume>: <fpage>309</fpage>-<lpage>315</lpage>, <year>2009</year>.<pub-id pub-id-type="pmid">19201917</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maesaka</surname><given-names>JK</given-names></name>, <name><surname>Miyawaki</surname><given-names>N</given-names></name>, <name><surname>Palaia</surname><given-names>T</given-names></name>, <name><surname>Fishbane</surname><given-names>S</given-names></name>, <name><surname>Durham</surname><given-names>JH</given-names></name></person-group>
<article-title>Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia</article-title>. <source>Kidney Int</source>
<volume>71</volume>: <fpage>822</fpage>-<lpage>826</lpage>, <year>2007</year>.<pub-id pub-id-type="pmid">17311074</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maesaka</surname><given-names>JK</given-names></name>, <name><surname>Imbriano</surname><given-names>L</given-names></name>, <name><surname>Mattana</surname><given-names>J</given-names></name>, <name><surname>Gallagher</surname><given-names>D</given-names></name>, <name><surname>Bade</surname><given-names>N</given-names></name>, <name><surname>Sharif</surname><given-names>S</given-names></name></person-group>
<article-title>Differentiating SIADH from cerebral/renal salt wasting: failure of the volume approach and need for a new approach to hyponatremia</article-title>. <source>J Clin Med</source>
<volume>3</volume>: <fpage>1373</fpage>-<lpage>1385</lpage>, <year>2014</year>.<pub-id pub-id-type="pmid">26237607</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steele</surname><given-names>A</given-names></name>, <name><surname>Gowrishankar</surname><given-names>M</given-names></name>, <name><surname>Abrahamson</surname><given-names>S</given-names></name>, <name><surname>Mazer</surname><given-names>CD</given-names></name>, <name><surname>Feldman</surname><given-names>RD</given-names></name>, <name><surname>Halperin</surname><given-names>ML</given-names></name></person-group>
<article-title>Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination</article-title>. <source>Ann Intern Med</source>
<volume>126</volume>: <fpage>20</fpage>-<lpage>25</lpage>, <year>1997</year>.<pub-id pub-id-type="pmid">8992919</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sherlock</surname><given-names>M</given-names></name>, <name><surname>Thompson</surname><given-names>CJ</given-names></name></person-group>
<article-title>The syndrome of inappropriate antidiuretic hormone: current and future management options</article-title>. <source>Eur J Endocrinol</source>
<volume>162</volume> (<issue>Suppl 1</issue>): <fpage>S13</fpage>-<lpage>S18</lpage>, <year>2010</year>.<pub-id pub-id-type="pmid">20164215</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Musch</surname><given-names>W</given-names></name>, <name><surname>Decaux</surname><given-names>G</given-names></name></person-group>
<article-title>Treating the syndrome of inappropriate ADH secretion with isotonic saline</article-title>. <source>QJM</source>
<volume>91</volume>: <fpage>749</fpage>-<lpage>753</lpage>, <year>1998</year>.<pub-id pub-id-type="pmid">10024938</pub-id></mixed-citation></ref></ref-list></back></article>